International

Clinical Care Options (CCO) recently announced it is developing a new program to support South African physicians and nurses in…

Over the past several years, we have written numerous times about legal settlements involving pharmaceutical companies who were…

Pfizer Inc. (Pfizer) recently announced the resolution of a previously disclosed investigation by the United States government…

  As the seventh largest economy in the world, “Brazil represents an attractive marketplace for any company in the healthcare…

Pharmaceutical purchases in Western Australia must meet the procurement policies set out by the State Supply Commission (SSC).…

Variations in CME Systems in Europe were outlined at the Global Alliance for Medical Education (GAME) which were discussed in a…

Last year, Johnson & Johnson announced that it will pay $70 million as part of a deferred prosecution agreement (DPA) with the…

“Medicines Australia (MA) is an industry association whose members represent multinational, research-based pharmaceutical…

While U.S. companies are preparing for the final regulations from CMS to implement the Physician Payment Sunshine Act, which will…

The European Medicines Agency (EMA)—Europe’s counterpart to the U.S. Food and Drug Administration (FDA)—recently issued…